Medical Device Industry Thought Leader and Serial Entrepreneur Dr. Thomas Fogarty to Participate at Medtech Insight and Windhover Information's 'In3 Medical Device Summit' Medical Technology Investment and Partnering Conference.

NEWPORT BEACH, Calif. -- June 21-23, 2006, The Palace Hotel, San Francisco 

Medtech Insight, a division of Windhover Information has announced that internationally recognized cardiovascular surgeon, inventor and entrepreneur, Tom Fogarty, M.D., will participate in an early-stage medical technology investment panel discussion titled "What are the Hot Deals Now and in the Future" at its upcoming "Investment In Innovation (In3) Medical Device Summit" Conference, being held June 21-23, 2006 at The Palace Hotel in San Francisco. The In3 Summit (www.meddevicesummit.com), the company's largest strategic investment and partnering event for medical technology executives, will feature presentations by over 60 emerging medtech companies seeking investment and/or funding opportunities, focused into 3 Tracks (Cardio/Peripheral Vascular, Spine and Orthopedics, and Other High-Growth Technologies), a 50 percent larger speaker faculty than past In3 events, more VC and large/mid-size company presentations, and focused workshops for start-up companies.

Dr. Fogarty has been a driving force in medical device innovation for nearly 40 years. From his first device, invented when he was still in college, until today, he has been a central figure in global device innovation, with more than 100 patents including the "industry standard" Fogarty balloon embolectomy catheter and the widely used AneuRx Stent Graft that replaces open-heart abdominal aortic aneurysm (AAA) surgery, more than 30 companies to his name and a host of distinguished awards. He played a key role in the early success of what is today Edwards Lifesciences and a founder of major device start-ups such as AneuRx, Biopsys Medical, CTS, and Novare, to name just a few. Dr. Fogarty is the recipient of countless awards and honors; most significantly, he is the recipient of the Jacobson Innovation Award of the American College of Surgeons, the 2000 Lemelson-MIT prize for Invention and Innovation and was inducted into the Inventors Hall of Fame in December 2001. The "What are the Hot Deals Now and in the Future" panel discussion, with other distinguished panelists including Rich Ferrari, Managing Director of De Novo Ventures and David L. Douglass, General Partner at Delphi Ventures, will focus on the following topics: where do the ideas come from; how to capitalize on the medtech industry; why invest in certain technologies and companies; rationale behind early-stage investments; and picks for deals of the year and why.

The 60+ emerging medical technology company presentations being spotlighted at the In3 Summit will each be followed by break-out sessions in private conference rooms. Track 1 (Cardiovascular and Peripheral Vascular Diagnostics and Therapeutics) presenters confirmed to date include Alchimer, Biophan Cardiovascular Division, Cardium Therapeutics, Design Medical, Edrich Health Technologies, Meridian Company, Percardia, Vascular Reconditioning, VasoGenix Pharmaceuticals, and Wireless 2000. Confirmed Track 2 (Orthopedics and Spine) presenters to date include BioMedical Enterprises, BioniCare Medical Technologies, Bone Solutions, CeraPedics, Conexis Biosciences, Disc Dynamics, ISTO Technologies, SpineVision, SpinX Technologies, St. Francis Medical Technologies, Tibion, and VitalWear. Track 3 presenters (Other High-Growth Technologies such as Drug Delivery, Gastrointestinal, General Surgery, Imaging, Metabolic Disorders, Neurology, Oncology, Ophthalmology, Tissue Engineering, and Uro/Gynecology, and Wound Management, among others) to date include BioImagene, Biomedix, Biosan Medical, CleveX, CoolTouch, CVAC Systems, EMcision, GlucoLight, Light Sciences New Technology Group, LiverCyte, Micro Medical Devices, Nanolution, Nanomix, Novashunt, Ogenix, Retanus, Smart Holograms, StemCapture, TyRx Pharma, Universal Medical Technologies, Vision Solutions Technologies, Vitality Medical Products, and VivoMedical. Prior to and during the event, attendees will also benefit from Medtech Insight's new Partnering Software, that allows attendees to access a wealth of searchable information on other attending companies, including detailed company and delegate profile information, a database of licensing opportunities, and the ability to communicate with and directly schedule meetings with prospective partners.

Additional speakers participating at the In3 Summit include Hanson S. Gifford, III, President and CEO, The Foundry; Hank Plain, Vice Chairman, The Foundry; Trevor Moody, Partner, Frazier Healthcare Ventures; Leslie Bottorff, General Partner, Medical Technology Onset Ventures; Sami Hamade, Vice President, Compass Group, Guidant Corporation; Brent Ahrens, General Partner, Canaan Partners; Bryant Zanko, Vice President, Business Development, Stryker Corporation; Alan Will, Managing Director, Split Rock Partners; and Michael Carusi, General Partner, Advanced Technology Ventures. In addition, David Cassak, Managing Partner at Windhover Information, will give the State of the Start-up Industry Address titled "A Market Analysis of Where Medical Technology Companies are Going." Visit the In3 Summit Web site at www.meddevicesummit.com for full event details.

The In3 Summit audience will represent the largest dealmakers in the worldwide medtech industry and healthcare investment community; attending companies include, among many others, 3M, Abbott Laboratories, Boston Scientific, Cardinal Health, Cook Group, Cordis, C.R. Bard, De Novo Ventures, DePuy/Johnson & Johnson, Earlybird Ventures, Edwards Lifesciences, Ethicon Endo-Surgery, Golden Gate Capital, Guidant, Hospira, Integra LifeSciences, Johnson & Johnson, KeyBanc Capital Markets, Kimberly-Clark, Kobayashi Pharmaceuticals of America, Krauth Medical, Lighthouse Capital Partners, Matignon Technologies FCPR, Morgan Stanley, Musculoskeletal Transplant Foundation, NASDAQ, Novartis Pharma, Olympus America, Prospect Venture Partners, Rodman & Renshaw, Rothschild, Smith & Nephew, Sorin, Stryker, The Aurora Funds, Thomas Weisel Healthcare Venture Partners, Three Arch Partners, Triathlon Medical Ventures, Terumo, Wilson Sonsini Goodrich & Rosati, and ZEVEX International.

Co-sponsors for the In3 Summit include AdvaMed, Battelle, Business Wire, Finnegan Henderson Farabow Garrett & Dunner LLP, Medical Capital Advisors, Medmarc and The Hartford, The Harvard Clinical Research Institute (HCRI), Reimbursement Principles, Ronald Trahan Associates, Teledyne Medical Microsystems, The MedTech Group, and Underwriters Laboratories.

To register, call Kristy Grimes of Medtech Insight at 480-985-9512, 888-202-5939 toll-free in the U.S., e-mail [e-mail], or register on the In3 Medical Device Summit Web site at www.meddevicesummit.com. Through April 28, 2006, attendees registering for the conference can save $100 off the $1,495 registration fee.

Medtech Insight's medical technology investment and partnering conferences have drawn over 5,850 attendees and more than 650 innovative early-stage presenting companies since their inception, making them the premier investment, partnering and networking event in the medical technology industry.

About Medtech Insight

Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. For more on the company's products and services, please see www.medtechinsight.com.